Education
Understanding chronic and recurrent UTIs
Clear, clinically grounded information to help healthcare professionals and patients understand the condition, the challenges, and the available approaches.
Why UTIs keep coming back
Recurrent UTIs affect millions of people, particularly women and elderly patients. Understanding why infections return is the first step towards breaking the cycle.
Why antibiotics don't solve the problem
Antibiotics treat the infection, but they don't address the underlying reason symptoms keep returning. Here's why a different approach may be needed.
What is the bladder lining / GAG layer?
The GAG layer is a protective coating inside the bladder. When damaged, it may contribute to recurring infections and persistent symptoms.
Non-antibiotic treatment approaches for bladder health
Beyond antibiotics, there are targeted approaches designed to support long-term bladder health by addressing the protective lining directly.
Clinical Evidence
Supporting clinical research
The following peer-reviewed papers support the clinical rationale behind intravesical hyaluronic acid therapy for chronic bladder conditions.
The Modern Approach to Intravesical Therapy of Chronic Cystitis
O.D. Nikitin — Bogomolets National Medical University, Kyiv
Men's Health, No. 4 (55), 2015
A clinical study of 30 patients with chronic cystitis treated with intravesical sodium hyaluronate (Instylan 80mg/50ml). Positive clinical dynamics were observed in 95% of patients, with cystitis recurrences reduced by more than 2-fold. Urination frequency decreased by 2.6× and pain above the pubis reduced by 63.3% after treatment.
Download paper (PDF)Intravesical Hyaluronic Acid — An Effective Option in the Treatment of Hemorrhagic Radiocystitis
S.P. Pasechnikov, V.N. Shilo — Bogomolets National Medical University / Cherkasy Regional Hospital
Medical Aspects of Men's Health, No. 1 (20), 2016
A prospective study of 18 patients with hemorrhagic cystitis following radiation therapy. Treatment with intravesical hyaluronic acid (Instylan) resulted in 87.5% complete remission at 6 months, sustained in 94% at 12 months. Urination frequency fell from 10.4 to 7.5 times per day, with no adverse reactions recorded.
Download paper (PDF)These papers are provided for educational purposes. Clinical decisions should be made in accordance with professional guidelines and individual patient assessment.